Global Health Limited (MEDANTA)

Loading page…

Global Health Limited (MEDANTA) · mywealthgrid

About

Global Health Limited is a hospital operator in India's healthcare services industry. With a market cap of ₹38,253 Cr and recent quarterly revenues in the ₹926–₹1,304 Cr range, it operates at mid-to-large scale. The company maintains operating margins around 20.84% and an ROE of 15.15%, positioning it as a profitable player in private healthcare.

Face value: ₹2

Market cap

₹36,498 Cr

P/E

65.6×

P/B

9.2×

Dividend yield

0.1%

ROE

15.1%

ROCE

16.9%

Debt / equity

0.3

OPM

20.8%

EPS (TTM)

₹20.7

Book value

₹147.4

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

High valuation (PE 68.78) leaves minimal room for earnings disappointment or multiple compression—verify revenue growth trajectory and what justifies the premium to peers.

Margin volatility: OPM ranges 18.55%–21.99% across recent quarters; understand the drivers (patient mix, capacity utilization, service pricing) and whether swings reflect operational risk or statistical noise.

Institutional selling pressure: FII stake declined from 10.15% to 9.46% in three months—verify whether this reflects fundamental concerns or sector rotation.

Bed occupancy, case complexity and patient retention metrics are not disclosed; verify these operational anchors to assess volume sustainability and pricing power.

Generated analysis · source review pending

Growth drivers

Low financial leverage (D/E 0.3) provides capacity for bed expansion or acquisitions without balance-sheet stress; verify capex plans and new facility timelines.

Stable profitability (net profit ₹79.9–₹158.4 Cr per quarter) generates recurring cash for reinvestment; verify capital allocation policy and reinvestment rate.

Margin stability around 20% (OPM 20.84% average, range 18.55%–21.99%) means volume growth directly accrets to profit; verify current bed occupancy rates and case volume trends.

Generated analysis · source review pending

954 historical price candles were omitted because the exchange source has not been verified.

₹1,357.3-4.1%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 20.8%
+Profit CAGR of 19.5% over the last 3 years
+Revenue CAGR of 17.9% over the last 3 years
+Comfortable interest coverage of 10.1×

Cons

−Expensive at 65.6× trailing earnings
−Trading at 9.2× book value
−Low dividend payout of 4.8% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

42/100

Business quality: 57
Growth: 62

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MIDCAP 150 NIFTY MIDSMALLCAP 400 NIFTY 500 NIFTY TOTAL MARKET

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	2,167	2,694	3,275	3,692	4,410
COGS	543	625	759	880	997
Gross profit	1,624	2,069	2,516	2,813	3,413
	1,173	1,457	1,717	1,936	2,494
	451	612	799	877	919
OPM %	20.8%	22.7%	24.4%	23.8%	20.8%
Depreciation	130	150	173	194	223
Interest	79	78	74	65	79
	39	65	75	29	98
Profit before tax	281	449	627	647	715
Tax	84	123	149	166	161
Tax %	30.1%	27.4%	23.8%	25.6%	22.5%
	196	326	478	481	554
PAT margin %	9.1%	12.1%	14.6%	13%	12.6%
EPS (₹)	—	12.6	17.8	17.9	20.7
EPS adjusted (₹)	7.8	12.2	17.8	17.9	20.7
	—	0%	0%	2.8%	2.4%
Annual report	—	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	82	51	54	54	54	54
Reserves	—	1,565	2,375	2,852	3,333	3,908
Minority interest	—	0	—	—	1	23
	—	838	842	419	328	1,190
	—	692	846	979	1,051	731
Total equity & liabilities	—	3,146	4,116	4,304	4,766	5,905
	1,616	1,776	1,713	1,817	1,982	3,795
CWIP	—	439	327	386	529	132
Investments	—	0	0	0	3	3
	—	930	2,076	2,101	2,253	1,975
Total assets	—	3,146	4,116	4,304	4,766	5,905

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	74.9%	76.8%	76.8%	76.2%	77.4%
EBITDA margin %	20.8%	22.7%	24.4%	23.8%	20.8%
EBIT margin %	14.8%	17.2%	19.1%	18.5%	15.8%
PAT margin %	9.1%	12.1%	14.6%	13%	12.6%
Working capital
Receivable days	30	26	24	29	34
Inventory days	36	35	32	28	29
Payable days	90	114	90	81	89
NWC days	-24	-52	-34	-24	-26
Leverage
Current ratio	1.94	2.76	2.44	2.48	2.67
Debt to EBITDA	1.86	1.38	0.52	0.37	1.29
Debt to equity	0.52	0.35	0.14	0.1	0.3
Interest coverage	4.5	6.8	9.5	11.7	10.1
Asset turnover	0.69	0.65	0.76	0.77	0.75
Return ratios
Return on assets %	6.2%	7.9%	11.1%	10.1%	9.4%
Return on capital employed %	13.2%	16.8%	19.4%	19.5%	16.9%
Return on equity %	12.1%	13.4%	16.5%	14.2%	14%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	33.06%	33.05%	33.04%	33.04%	33.04%	33.03%	33.03%	33.01%	33.01%	33.01%	33.01%	33%
	10.69%	11.36%	12.09%	12.94%	12.2%	12.47%	11.76%	11.54%	11.4%	10.53%	10.15%	9.46%
	10.93%	11.15%	10.25%	10.57%	11.11%	10.51%	11.93%	12.2%	12.98%	14%	14.76%	16.89%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	45.32%	44.44%	44.62%	43.45%	43.65%	43.99%	43.28%	43.19%	42.55%	42.4%	42.01%	40.56%
No. of shareholders	—	—	—	—	—	—	—	—	1,55,806	1,51,241	1,47,390	1,40,531

Promoter holding down 0.06 percentage points since Sep 2023.

13 deals · 16 Nov 2022 – 25 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
25 Jun 2026	SUNIL SACHDEVA	Block	BSE	Sell	10,00,000	₹1,300.00	₹130.00 Cr
25 Jun 2026	HDFC MUTUAL FUND	Block	BSE	Buy	10,00,000	₹1,300.00	₹130.00 Cr
25 May 2026	SUNIL SACHDEVA	Block	NSE	Sell	10,00,000	₹1,225.00	₹122.50 Cr
25 May 2026	HDFC MUTUAL FUND	Block	NSE	Buy	10,00,000	₹1,225.00	₹122.50 Cr
14 Feb 2024	JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED	Bulk	BSE	Buy	30,00,000	₹1,315.22	₹394.57 Cr
14 Feb 2024	JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED	Bulk	BSE	Sell	30,00,000	₹1,315.05	₹394.52 Cr
14 Feb 2024	DUNEARN INVESTMENTS MAURITIUS PTE LIMITED	Bulk	BSE	Sell	30,00,000	₹1,315.20	₹394.56 Cr
14 Feb 2024	RJ CORP LIMITED	Bulk	BSE	Buy	28,82,203	₹1,315.00	₹379.01 Cr
18 Jan 2024	THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT	Block	BSE	Buy	2,97,792	₹1,030.05	₹30.67 Cr
18 Jan 2024	JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED	Block	BSE	Sell	2,97,792	₹1,030.05	₹30.67 Cr

1–10 of 13

1 / 2

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Naresh TrehanExecutive Director-Chairperson related to Promoter-MD
Mr. Pankaj Prakash SahniExecutive Director-CEO
Mr. Hari Shanker BhartiaNon-Executive - Independent Director
Ms. Praveen MahajanNon-Executive - Independent Director
Mr. Rajan Bharti MittalNon-Executive - Independent Director
Mr. Ravi GuptaNon-Executive - Independent Director
Mr. Ravi Kant JaipuriaNon-Executive - Nominee Director
Ms. Shonan Purie TrehanNon-Executive - Non Independent Director
Mr. Sunil SachdevaNon-Executive - Non Independent Director
Mr. Vikram Singh MehtaNon-Executive - Independent Director
Mr. Yogesh Kumar GuptaChief Financial Officer

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 14 fund houses

Held by these funds

5.3%

of the company's equity

All mutual funds

16.03%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

55 schemes · 14 fund houses

		Shares
Portfolio of Kotak Mid Cap FundNEW	Kotak Mahindra Mutual Fund	88.83 L	1,314.46	1.84%	3.304%	—
Healthcare Opportunities Fund	SBI Mutual Fund	7.5 L	110.98	1.91%	0.279%	+1.1 L
Portfolio of Kotak Contra Fund	Kotak Mahindra Mutual Fund	6.13 L	90.73	1.65%	0.228%	-0
Midcap FundNEW	Axis Mutual Fund	5.92 L	87.57	0.25%	0.22%	—
Franklin India Multi Cap Fund	Franklin Templeton Mutual Fund	5.6 L	82.85	1.57%	0.208%	-4.51 L
Multicap FundNEW	Axis Mutual Fund	4.72 L	69.86	0.58%	0.176%	—
Multi Asset Allocation Fund	Nippon India Mutual Fund	2.35 L	34.79	0.19%	0.087%	-0
Flexi CapNEW	360 ONE Mutual Fund	2.3 L	34	1.51%	0.085%	—

1–8 of 55

1 / 7

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Jul 2026TranscriptAI SummaryPPT REC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

2

Final dividend14 Aug 2026 · ex-date₹0.5
Final dividend22 Aug 2025 · ex-date₹0.5

1

Board meeting to consider results30 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

38 announcementsExport CSV

29 Sept 2026, 12:07 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

Loading announcements…

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	74.9%	76.8%	76.8%	76.2%	77.4%
EBITDA margin %	20.8%	22.7%	24.4%	23.8%	20.8%
EBIT margin %	14.8%	17.2%	19.1%	18.5%	15.8%
PAT margin %	9.1%	12.1%	14.6%	13%	12.6%
Working capital
Receivable days	30	26	24	29	34
Inventory days	36	35	32	28	29
Payable days	90	114	90	81	89
NWC days	-24	-52	-34	-24	-26
Leverage
Current ratio	1.94	2.76	2.44	2.48	2.67
Debt to EBITDA	1.86	1.38	0.52	0.37	1.29
Debt to equity	0.52	0.35	0.14	0.1	0.3
Interest coverage	4.5	6.8	9.5	11.7	10.1
Asset turnover	0.69	0.65	0.76	0.77	0.75
Return ratios
Return on assets %	6.2%	7.9%	11.1%	10.1%	9.4%
Return on capital employed %	13.2%	16.8%	19.4%	19.5%	16.9%
Return on equity %	12.1%	13.4%	16.5%	14.2%	14%

Date	Category	Subject	Filing
29 Sept 2026, 12:07 pm	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF
28 Sept 2026, 1:37 pm	Company Update General	Intimation Under Regulation 30 Of The Listing Regulations.	PDF
22 Sept 2026, 4:59 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
22 Sept 2026, 4:43 pm	Company Update Allotment of ESOP / ESPS	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS	PDF
17 Sept 2026, 1:24 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
16 Sept 2026, 6:21 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
16 Sept 2026, 4:03 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
11 Sept 2026, 4:20 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	311	645	612	624	714
	-421	-342	-441	-721	-1,065
	160	346	-514	-97	248
Net cash flow	50	648	-343	-194	-103
Free cash flow	37	409	334	107	-124
CFO / Operating profit %	69%	105.3%	76.6%	71.1%	77.7%

Global Health Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

2

1

Announcements

2

1

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Global Health Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Dividends2

Board meetings1

Announcements

Dividends2

Board meetings1

Ratio timeline

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

2

1

2

1